Purpose
to de-risk a programmable CRISPR Cas13 modality in a proof of concept mouse study with the long term goal of developing a novel class of programmable pan-antiviral therapeutics that could be rapidly deployed in future pandemics
Grantee
Division
Global Health
Date
NOVEMBER 2021
Region served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
11
Grantee location
Princeton, New Jersey, United States
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.